MONOVISC
MONOVISC is a range of orthopaedic viscosupplements from Anika Therapeutics, Inc., made in the United States as CE-marked medical devices for qualified practitioners only. Monovisc is a single-injection intra-articular viscosupplement of lightly cross-linked, non-animal sodium hyaluronate, designed to supplement the hyaluronic acid naturally present in the synovial fluid. It is intended for use in osteoarthritis of the knee, hip, shoulder and ankle joints in patients who have not responded adequately to conservative non-pharmacologic therapy and simple analgesics. All units are original and batch traceable. Wholesale prices are available only to registered or approved users. Register, log in or contact our team to request wholesale access, check availability and receive product documentation.
available
categories
ready
1 references · 1 product categories
Ортопедия
We supply only original MONOVISC products with guaranteed authenticity.
Certificates, batch records and customs paperwork available for every order.
Held in EU bond and shipped worldwide with cold-chain where required.
Reserved for licensed practitioners, clinics and pharmacies.
FAQ
Which joints is MONOVISC used on?
Monovisc is used in the knee, hip, shoulder and ankle joints affected by osteoarthritis. It is intended for patients who have not responded adequately to conservative non-pharmacologic therapy and simple analgesics.
What is the MONOVISC treatment protocol?
Monovisc is administered as a single intra-articular injection of 4 mL. It must not be injected into infected or inflamed joints or intravascularly.
How is MONOVISC supplied?
Each box contains one pre-filled 5 mL syringe holding 4 mL of product, with 88 mg of sodium hyaluronate (22 mg/mL) produced by bacterial fermentation.